Bladder cancer vaccine - Organon TeknikaAlternative Names: OncoTICE
Latest Information Update: 20 Oct 2009
At a glance
- Originator Organon Teknika
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Bladder cancer
Most Recent Events
- 29 Dec 1999 New profile, split from generic Bladder cancer vaccine profile